The<unk>  is a therapeutic bleeding risk stratification score for those on oral anticoagulants in atrial fibrillation. It is recommended by the new European Society of Cardiology guidelines and the Canadian guidelines on atrial fibrillation management. This score would help as a potential practical tool in clinical decision making, rather than 'guessing' the bleeding risk. Also, the<unk>  makes clinicians think about addressing any correctable bleeding risk factors (eg. uncontrolled hypertension, coadministration of NSAIDs or aspirin, etc). It is matched to the CHA2DS2-VASc score used for stroke risk stratification. In a recent article validating the score, diabetes and left ventricular dysfunction were identified as additional risk factors for bleeding.
HAS-BLED score
Manchester score
Rogers score
PRECISE-DAPT score
Gleason score
AMUSE score
Alvarado score
Tygerberg score